Here we demonstrate, similar to previous reports using rapamycin [8,9], that RAD001 is highly effective in suppressing the growth of Tsc mouse kidney cystadenomas, with an average 99% reduction in tumor cell burden in this ENU-accelerated Tsc2+- model. Here, TSC2 is linked to tuberous sclerosis.